Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:9596684rdf:typepubmed:Citationlld:pubmed
pubmed-article:9596684lifeskim:mentionsumls-concept:C0007634lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1326205lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0001128lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0010656lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0040085lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0085862lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1299583lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0442805lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C2261841lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C2825492lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1882074lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C2346927lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0851827lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1701901lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1608386lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C1549571lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0686907lld:lifeskim
pubmed-article:9596684lifeskim:mentionsumls-concept:C0657233lld:lifeskim
pubmed-article:9596684pubmed:issue11lld:pubmed
pubmed-article:9596684pubmed:dateCreated1998-6-26lld:pubmed
pubmed-article:9596684pubmed:abstractTextThymidylate synthase (TS) inhibition causes cell death, and this enzyme is the target for the important chemotherapy regime 5-fluorouracil/leucovorin. GW1843 (1843U89) is a potent and specific folate analog TS inhibitor in clinical development. Because of the importance of TS as a chemotherapy target, we are studying the mechanism of TS inhibition-induced cell death by GW1843. Ceramide is a regulatory lipid generated by the action of sphingomyelinase and is believed to signal apoptosis. The role of the ceramide in apoptotic signaling was studied in Molt-4 human T-cell leukemia cells undergoing cell death after treatment with GW1843. In response to GW1843, Molt-4 cells undergo apoptosis with both acidic pH, Mg2+-independent sphingomyelinase (ASMase) and neutral pH, Mg2+-dependent sphingomyelinase (NSMase) activities elevated as early steps in the initiation of apoptosis before Molt-4 commitment to death. These activities lead to ceramide production with kinetics consistent with a role as an effector molecule signaling the initiation of apoptosis in Molt-4 cells. These changes were found to be independent of caspase 3-like (CPP32/apopain) activity and DNA degradation, but were not separable from membrane blebbing or cell lysis in this cell line. In this report, kinetic evidence is provided for a role of ceramide in initiating GW1843-induced cell death of Molt-4 T-cell leukemia cells.lld:pubmed
pubmed-article:9596684pubmed:languageenglld:pubmed
pubmed-article:9596684pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:citationSubsetAIMlld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:9596684pubmed:statusMEDLINElld:pubmed
pubmed-article:9596684pubmed:monthJunlld:pubmed
pubmed-article:9596684pubmed:issn0006-4971lld:pubmed
pubmed-article:9596684pubmed:authorpubmed-author:SmithG KGKlld:pubmed
pubmed-article:9596684pubmed:authorpubmed-author:StrumJ CJClld:pubmed
pubmed-article:9596684pubmed:authorpubmed-author:HannunY AYAlld:pubmed
pubmed-article:9596684pubmed:authorpubmed-author:SundsethRRlld:pubmed
pubmed-article:9596684pubmed:authorpubmed-author:SextonC JCJlld:pubmed
pubmed-article:9596684pubmed:authorpubmed-author:LaethemR MRMlld:pubmed
pubmed-article:9596684pubmed:authorpubmed-author:JayadevSSlld:pubmed
pubmed-article:9596684pubmed:issnTypePrintlld:pubmed
pubmed-article:9596684pubmed:day1lld:pubmed
pubmed-article:9596684pubmed:volume91lld:pubmed
pubmed-article:9596684pubmed:ownerNLMlld:pubmed
pubmed-article:9596684pubmed:authorsCompleteYlld:pubmed
pubmed-article:9596684pubmed:pagination4350-60lld:pubmed
pubmed-article:9596684pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:meshHeadingpubmed-meshheading:9596684-...lld:pubmed
pubmed-article:9596684pubmed:year1998lld:pubmed
pubmed-article:9596684pubmed:articleTitleIncreases in neutral, Mg2+-dependent and acidic, Mg2+-independent sphingomyelinase activities precede commitment to apoptosis and are not a consequence of caspase 3-like activity in Molt-4 cells in response to thymidylate synthase inhibition by GW1843.lld:pubmed
pubmed-article:9596684pubmed:affiliationInternational Science Development Group, Glaxo Wellcome Inc, Research Triangle Park, NC 27709, USA.lld:pubmed
pubmed-article:9596684pubmed:publicationTypeJournal Articlelld:pubmed